Artemisinic Acid Market to Grow with a CAGR of 4.10 % through 2029
High incidence of malaria is expected to drive the
Global Artemisinic Acid Market growth in the forecast period, 2025-2029.
According to
TechSci Research report, “Artemisinic Acid Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2029”, the
Global Artemisinic Acid Market stood at USD 501.34 Million in 2023 and is
anticipated to grow with a CAGR of 4.10% in the forecast period, 2025-2029. The market's growth can be attributed to the widespread occurrence of malaria, particularly in developing and underdeveloped economies. Initiatives led by public organizations aimed at raising awareness about malaria treatment and increased research efforts in malaria treatment are anticipated to drive market expansion throughout the forecast period. In March 2020, the WHO urged countries in Africa with high malaria case rates to maintain malaria services such as detection, treatment, and prevention despite the pandemic, likely bolstering the market during this period. Furthermore, ongoing efforts by these public organizations to eradicate malaria by enhancing access to treatment are expected to bolster the market in the post-pandemic era.
The substantial disease burden and the considerable number of fatalities attributed to malaria are anticipated to drive demand for advanced treatment alternatives, presenting opportunities for artemisinic acid in disease management. Public organizations worldwide have initiated efforts to enhance access to effective malaria treatment, aiming to mitigate the mortality rates associated with the disease.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Artemisinic Acid Market”
In 2021, the World Health Organization (WHO), under the Malaria Elimination initiative, aimed to facilitate access to malaria diagnosis, prevention, and treatment as part of universal health coverage. Such endeavors by public organizations to provide cost-effective treatment options are projected to stimulate demand for treatments like artemisinic acid, thereby bolstering market growth. Artemisinin-based combination therapies (ACT) currently serve as the primary treatment for malaria in endemic countries worldwide. Artemisinin, a key component of ACT, is derived from the synthesis of artemisinic acid. The widespread use of Artemisinin and the cost efficiency of Artemisinin derived from artemisinic acid are expected to drive demand for artemisinic acid production for malaria treatment. This is anticipated to enhance its adoption, particularly in endemic regions, further supporting market expansion.
The Global Artemisinic
Acid Market is segmented into Type, Applications,
regional distribution, and company.
Based on Applications,
the antimalarial tablets segment has emerged as the predominant market leader, the
segment will continue to grow at a significant rate during the forecast period.
Tablets are an oral way of drug administration. Tablets are self-administering
and do not require a trained physician for drug administration, which is one of
the major reasons for the high acceptance of tablet formulations. Moreover,
tablet formulations offer high patient compliance, accurate dosing, control of
drug release, and stability. This further improves the demand for antimalarial
tablet formulations in the market.
Based on the
Regional, Middle East & Africa segment
is expected to grow during the forecast period. The regional market growth is
expected to grow at the fastest rate according to the forecast. Africa is one
of the major countries which suffers significantly from malaria. For instance,
UNICEF reports that every minute a child under 5 years dies from malaria in
Africa. In MEA, public organizations are keen to provide treatment to reduce
the number of deaths associated with the disease. For
instance, the WHO in 2021 stated that The African Region of the WHO accounts
for a large part of the global malaria burden. In 2021, the region accounted to
have 95% of malaria cases and 96% of malaria deaths. The high burden of the
disease and the initiative by public organizations to raise awareness regarding
the treatment for malaria is benefiting the growth of the regional market.
Major companies
operating in Global Artemisinic Acid Market are:
- Sanofi SA
- KPC Pharmaceuticals, Inc
- Guilin Pharmaceutical Co., Ltd
- Calyx Chemicals and Pharmaceuticals
Ltd.
- Novartis AG
- Ipca Laboratories Ltd.
- Cipla Inc.
- Shin Poong Pharm Co., Ltd.
- Rupus Global Limited
- AdvacarePharma
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“Growth can be
attributed to the high burden of malaria in underdeveloped and developing
economies, many research studies concerning Malaria, and initiatives by public
organizations such as the WHO, UNICEF, and others. These organizations are
committed to controlling the incidences of malaria globally by creating
awareness about malaria treatment. Moreover,
tablet formulations offer high patient compliance, accurate dosing, control of
drug release, and stability. This further improves the demand for antimalarial
tablet formulations in the market. The
high number of hospitalizations due to malaria worldwide is expected to boost
the segment market growth further.,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Artemisinic Acid Market- Global Industry Size, Share, Forecast & Opportunity, Segmented By Type
(Total Synthesis, Semi synthesis), By Applications (Antimalarial Injections,
Antimalarial Tablets), By Region, By
Competition, 2019-2029F”,
has evaluated the future growth potential of Global Artemisinic Acid Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Artemisinic Acid Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Email: [email protected]
Website: https://www.techsciresearch.com